A Pilot Study to Evaluate the Efficacy of Class IV Lasers on Nonhealing Neuroischemic Diabetic Foot Ulcers in Patients With Type 2 Diabetes
Diabetic foot ulcers (DFUs) represent a disabling complication of diabetes that has a devastating impact on the quality of life and predict lower-limb amputation and premature mortality. Despite best practice, 30–40% of DFUs do not heal within 12–20 weeks. Novel therapeutic agents have been tested in clinical trials, and it has been estimated that ;30–50% of patients with neuropathic DFUs receiving these new treatments have healed by 12–20 weeks.
“Therapy lasers have been an exciting addition to the health care treatment arsenal. The development of Class IV therapy lasers represents the next generation of light therapy. By maximizing the primary effects, Class IV therapy lasers are able to induce extremely rapid clinical responses. Progressive health care providers wanting to offer the latest technology to their clientele should investigate Class IV therapy lasers.”
— Dr. Julian Vickers (deceased)
Note from Dr. Phil
Dr. Julian was taken away from us too soon. He passed away in 2009, shortly after he and I authored this article on Class 4 Laser Therapy. He was a good man. I think of him often, and I look forward to seeing him again on the other side.